Global Cancer Immunotherapy Market Growth (Status and Outlook) 2022-2028
- LP 4802715
- 86 Pages
- January 2022
- Pharmaceuticals
The United States Cancer Immunotherapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cancer Immunotherapy market, reaching US$ million by the year 2028. As for the Europe Cancer Immunotherapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cancer Immunotherapy players cover Amgen, AstraZeneca, Roche, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amgen
AstraZeneca
Roche
Bayer
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Immunotherapy Market Size 2017-2028
2.1.2 Cancer Immunotherapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Cancer Immunotherapy Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Immune Checkpoint Inhibitors
2.2.3 Immune System Modulators
2.2.4 Cancer Vaccines
2.3 Cancer Immunotherapy Market Size by Type
2.3.1 Cancer Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Cancer Immunotherapy Market Size Market Share by Type (2017-2022)
2.4 Cancer Immunotherapy Segment by Application
2.4.1 Lung Cancer
2.4.2 Breast Cancer
2.4.3 Colorectal Cancer
2.4.4 Melanoma
2.4.5 Prostate Cancer
2.4.6 Others
2.5 Cancer Immunotherapy Market Size by Application
2.5.1 Cancer Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Cancer Immunotherapy Market Size Market Share by Application (2017-2022)
3 Cancer Immunotherapy Market Size by Player
3.1 Cancer Immunotherapy Market Size Market Share by Players
3.1.1 Global Cancer Immunotherapy Revenue by Players (2020-2022)
3.1.2 Global Cancer Immunotherapy Revenue Market Share by Players (2020-2022)
3.2 Global Cancer Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cancer Immunotherapy by Regions
4.1 Cancer Immunotherapy Market Size by Regions (2017-2022)
4.2 Americas Cancer Immunotherapy Market Size Growth (2017-2022)
4.3 APAC Cancer Immunotherapy Market Size Growth (2017-2022)
4.4 Europe Cancer Immunotherapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Cancer Immunotherapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Cancer Immunotherapy Market Size by Country (2017-2022)
5.2 Americas Cancer Immunotherapy Market Size by Type (2017-2022)
5.3 Americas Cancer Immunotherapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Immunotherapy Market Size by Region (2017-2022)
6.2 APAC Cancer Immunotherapy Market Size by Type (2017-2022)
6.3 APAC Cancer Immunotherapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cancer Immunotherapy by Country (2017-2022)
7.2 Europe Cancer Immunotherapy Market Size by Type (2017-2022)
7.3 Europe Cancer Immunotherapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cancer Immunotherapy by Region (2017-2022)
8.2 Middle East & Africa Cancer Immunotherapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Cancer Immunotherapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cancer Immunotherapy Market Forecast
10.1 Global Cancer Immunotherapy Forecast by Regions (2023-2028)
10.1.1 Global Cancer Immunotherapy Forecast by Regions (2023-2028)
10.1.2 Americas Cancer Immunotherapy Forecast
10.1.3 APAC Cancer Immunotherapy Forecast
10.1.4 Europe Cancer Immunotherapy Forecast
10.1.5 Middle East & Africa Cancer Immunotherapy Forecast
10.2 Americas Cancer Immunotherapy Forecast by Country (2023-2028)
10.2.1 United States Cancer Immunotherapy Market Forecast
10.2.2 Canada Cancer Immunotherapy Market Forecast
10.2.3 Mexico Cancer Immunotherapy Market Forecast
10.2.4 Brazil Cancer Immunotherapy Market Forecast
10.3 APAC Cancer Immunotherapy Forecast by Region (2023-2028)
10.3.1 China Cancer Immunotherapy Market Forecast
10.3.2 Japan Cancer Immunotherapy Market Forecast
10.3.3 Korea Cancer Immunotherapy Market Forecast
10.3.4 Southeast Asia Cancer Immunotherapy Market Forecast
10.3.5 India Cancer Immunotherapy Market Forecast
10.3.6 Australia Cancer Immunotherapy Market Forecast
10.4 Europe Cancer Immunotherapy Forecast by Country (2023-2028)
10.4.1 Germany Cancer Immunotherapy Market Forecast
10.4.2 France Cancer Immunotherapy Market Forecast
10.4.3 UK Cancer Immunotherapy Market Forecast
10.4.4 Italy Cancer Immunotherapy Market Forecast
10.4.5 Russia Cancer Immunotherapy Market Forecast
10.5 Middle East & Africa Cancer Immunotherapy Forecast by Region (2023-2028)
10.5.1 Egypt Cancer Immunotherapy Market Forecast
10.5.2 South Africa Cancer Immunotherapy Market Forecast
10.5.3 Israel Cancer Immunotherapy Market Forecast
10.5.4 Turkey Cancer Immunotherapy Market Forecast
10.5.5 GCC Countries Cancer Immunotherapy Market Forecast
10.6 Global Cancer Immunotherapy Forecast by Type (2023-2028)
10.7 Global Cancer Immunotherapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Cancer Immunotherapy Product Offered
11.1.3 Amgen Cancer Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Cancer Immunotherapy Product Offered
11.2.3 AstraZeneca Cancer Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Cancer Immunotherapy Product Offered
11.3.3 Roche Cancer Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Cancer Immunotherapy Product Offered
11.4.3 Bayer Cancer Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Cancer Immunotherapy Product Offered
11.5.3 Bristol-Myers Squibb Cancer Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Information
11.6.2 Eli Lilly Cancer Immunotherapy Product Offered
11.6.3 Eli Lilly Cancer Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Eli Lilly Main Business Overview
11.6.5 Eli Lilly Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Cancer Immunotherapy Product Offered
11.7.3 Merck Cancer Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Cancer Immunotherapy Product Offered
11.8.3 Novartis Cancer Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Cancer Immunotherapy Product Offered
11.9.3 Pfizer Cancer Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
12 Research Findings and Conclusion
Table 1. Cancer Immunotherapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Immune Checkpoint Inhibitors
Table 4. Major Players of Immune System Modulators
Table 5. Major Players of Cancer Vaccines
Table 6. Cancer Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Cancer Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Cancer Immunotherapy Market Size Market Share by Type (2017-2022)
Table 9. Cancer Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Cancer Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Cancer Immunotherapy Market Size Market Share by Application (2017-2022)
Table 12. Global Cancer Immunotherapy Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Cancer Immunotherapy Revenue Market Share by Player (2020-2022)
Table 14. Cancer Immunotherapy Key Players Head office and Products Offered
Table 15. Cancer Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cancer Immunotherapy Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Cancer Immunotherapy Market Size Market Share by Regions (2017-2022)
Table 20. Americas Cancer Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Cancer Immunotherapy Market Size Market Share by Country (2017-2022)
Table 22. Americas Cancer Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Cancer Immunotherapy Market Size Market Share by Type (2017-2022)
Table 24. Americas Cancer Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Cancer Immunotherapy Market Size Market Share by Application (2017-2022)
Table 26. APAC Cancer Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Cancer Immunotherapy Market Size Market Share by Region (2017-2022)
Table 28. APAC Cancer Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Cancer Immunotherapy Market Size Market Share by Type (2017-2022)
Table 30. APAC Cancer Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Cancer Immunotherapy Market Size Market Share by Application (2017-2022)
Table 32. Europe Cancer Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Cancer Immunotherapy Market Size Market Share by Country (2017-2022)
Table 34. Europe Cancer Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Cancer Immunotherapy Market Size Market Share by Type (2017-2022)
Table 36. Europe Cancer Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Cancer Immunotherapy Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Cancer Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Cancer Immunotherapy Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Cancer Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Cancer Immunotherapy Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Cancer Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Cancer Immunotherapy Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Cancer Immunotherapy
Table 45. Key Market Challenges & Risks of Cancer Immunotherapy
Table 46. Key Industry Trends of Cancer Immunotherapy
Table 47. Global Cancer Immunotherapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Cancer Immunotherapy Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Cancer Immunotherapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Cancer Immunotherapy Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Cancer Immunotherapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Cancer Immunotherapy Market Size Market Share Forecast by Application (2023-2028)
Table 53. Amgen Details, Company Type, Cancer Immunotherapy Area Served and Its Competitors
Table 54. Amgen Cancer Immunotherapy Product Offered
Table 55. Amgen Cancer Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Amgen Main Business
Table 57. Amgen Latest Developments
Table 58. AstraZeneca Details, Company Type, Cancer Immunotherapy Area Served and Its Competitors
Table 59. AstraZeneca Cancer Immunotherapy Product Offered
Table 60. AstraZeneca Main Business
Table 61. AstraZeneca Cancer Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. AstraZeneca Latest Developments
Table 63. Roche Details, Company Type, Cancer Immunotherapy Area Served and Its Competitors
Table 64. Roche Cancer Immunotherapy Product Offered
Table 65. Roche Main Business
Table 66. Roche Cancer Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Roche Latest Developments
Table 68. Bayer Details, Company Type, Cancer Immunotherapy Area Served and Its Competitors
Table 69. Bayer Cancer Immunotherapy Product Offered
Table 70. Bayer Main Business
Table 71. Bayer Cancer Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Bayer Latest Developments
Table 73. Bristol-Myers Squibb Details, Company Type, Cancer Immunotherapy Area Served and Its Competitors
Table 74. Bristol-Myers Squibb Cancer Immunotherapy Product Offered
Table 75. Bristol-Myers Squibb Main Business
Table 76. Bristol-Myers Squibb Cancer Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Bristol-Myers Squibb Latest Developments
Table 78. Eli Lilly Details, Company Type, Cancer Immunotherapy Area Served and Its Competitors
Table 79. Eli Lilly Cancer Immunotherapy Product Offered
Table 80. Eli Lilly Main Business
Table 81. Eli Lilly Cancer Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Eli Lilly Latest Developments
Table 83. Merck Details, Company Type, Cancer Immunotherapy Area Served and Its Competitors
Table 84. Merck Cancer Immunotherapy Product Offered
Table 85. Merck Main Business
Table 86. Merck Cancer Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Merck Latest Developments
Table 88. Novartis Details, Company Type, Cancer Immunotherapy Area Served and Its Competitors
Table 89. Novartis Cancer Immunotherapy Product Offered
Table 90. Novartis Main Business
Table 91. Novartis Cancer Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Novartis Latest Developments
Table 93. Pfizer Details, Company Type, Cancer Immunotherapy Area Served and Its Competitors
Table 94. Pfizer Cancer Immunotherapy Product Offered
Table 95. Pfizer Main Business
Table 96. Pfizer Cancer Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Pfizer Latest Developments
List of Figures
Figure 1. Cancer Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Immunotherapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Cancer Immunotherapy Market Size Market Share by Type in 2021
Figure 7. Cancer Immunotherapy in Lung Cancer
Figure 8. Global Cancer Immunotherapy Market: Lung Cancer (2017-2022) & ($ Millions)
Figure 9. Cancer Immunotherapy in Breast Cancer
Figure 10. Global Cancer Immunotherapy Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 11. Cancer Immunotherapy in Colorectal Cancer
Figure 12. Global Cancer Immunotherapy Market: Colorectal Cancer (2017-2022) & ($ Millions)
Figure 13. Cancer Immunotherapy in Melanoma
Figure 14. Global Cancer Immunotherapy Market: Melanoma (2017-2022) & ($ Millions)
Figure 15. Cancer Immunotherapy in Prostate Cancer
Figure 16. Global Cancer Immunotherapy Market: Prostate Cancer (2017-2022) & ($ Millions)
Figure 17. Cancer Immunotherapy in Others
Figure 18. Global Cancer Immunotherapy Market: Others (2017-2022) & ($ Millions)
Figure 19. Global Cancer Immunotherapy Market Size Market Share by Application in 2021
Figure 20. Global Cancer Immunotherapy Revenue Market Share by Player in 2021
Figure 21. Global Cancer Immunotherapy Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Cancer Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 23. APAC Cancer Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 24. Europe Cancer Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Cancer Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 26. Americas Cancer Immunotherapy Value Market Share by Country in 2021
Figure 27. Americas Cancer Immunotherapy Consumption Market Share by Type in 2021
Figure 28. Americas Cancer Immunotherapy Market Size Market Share by Application in 2021
Figure 29. United States Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Cancer Immunotherapy Market Size Market Share by Region in 2021
Figure 34. APAC Cancer Immunotherapy Market Size Market Share by Application in 2021
Figure 35. China Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Cancer Immunotherapy Market Size Market Share by Country in 2021
Figure 42. Europe Cancer Immunotherapy Market Size Market Share by Type in 2021
Figure 43. Europe Cancer Immunotherapy Market Size Market Share by Application in 2021
Figure 44. Germany Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Cancer Immunotherapy Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Cancer Immunotherapy Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Cancer Immunotherapy Market Size Market Share by Application in 2021
Figure 52. Egypt Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Cancer Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 58. APAC Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 59. Europe Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 61. United States Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 62. Canada Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 65. China Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 66. Japan Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 67. Korea Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 69. India Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 70. Australia Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 71. Germany Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 72. France Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 73. UK Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 74. Italy Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 75. Russia Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 76. Spain Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 79. Israel Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Cancer Immunotherapy Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
